Acute pulmonary coccidioidomycosis is a lung infection caused by breathing in spores of Coccidioides immitis or Coccidioides posadasii, fungi found in the soil in certain parts of the southwestern U.S., Mexico, and Central and South America.
See also:
Coccidioides infection begins in the lungs after a person breathes in the spores.
Those who are at higher risk of developing more serious Coccidioides infection include:
Occasionally the infection may develop into a long-term (chronic) lung disease or can reactivate after a long latent period.
Traveling to an area where these fungi are found is a risk for coccidioidal infection. Areas in the U.S. include southwestern New Mexico, Arizona, California (especially the San Joaquin Valley), and western Texas.
Most of the time, people with this time of infection never have symptoms. In other people, the symptoms range from mild, cold- or flu-like symptoms to severe pneumonia.
If they occur, symptoms start about 5 to 21 days after you come into contact with the fungus. They may include:
Rarely, the infection spreads from the lungs through the bloodstream to involve the skin, bones, joints, lymph nodes, and central nervous system or other organs. See: Disseminated coccidioidomycosis
The health care provider will perform a physical exam and listen to your lungs with a stethoscope. The following tests may be done:
The acute form of coccidiodomycosis usually goes away without treatment. Your health care provider may recommend bedrest and treatment of flu-like symptoms until your fever disappears.
If you have a weakened immune system, you may need antifungal treatment with amphotericin B, fluconazole, or itraconazole. The best length of treatment with these medications has not been determined.
In most cases, the outlook is good.
Call your health care provider if:
Avoiding travel to regions where this fungus is found will prevent this disorder. However, this is not practical or possible for many people. You should avoid contact with soil in these regions if you have a weakened immune system due to HIV or other conditions.
Davies SF, Knox KS, Serosi GA. Fungal infections. In: Mason RJ, Broaddus VC, Martin TR, et al. Murray & Nadel's Textbook of Respiratory Medicine. 5th ed. Philadelphia, Pa: Saunders Elsevier; 2010:chap 34.
Galgiani JN. Coccidioidomycosis. In: Goldman L, Ausiello D, eds. Cecil Medicine. 23rd ed. Philadelphia, Pa: Saunders Elsevier; 2007:chap 354.
Disclaimer: The information contained in this website, and its associated websites, is provided as a benefit to the local community, and the Internet community in general; it does not constitute medical advice. We try to provide quality information, but we make no claims, promises or guarantees about the accuracy, completeness, or adequacy of the information contained in or linked to this website and its associated sites. As medical advice must be tailored to the specific circumstances of each patient and healthcare is constantly changing, nothing provided herein should be used as a substitute for the advice of a competent physician. Furthermore, in providing this service, Adventist HealthCare does not condone or support all of the content covered in this site. As an Adventist health care organization, Adventist HealthCare acts in accordance with the ethical and religious directives for Adventist health care services.